All countries

Product-level innovation boosts gastrointestinal stent adoption

Asia Pacific is estimated to register the highest CAGR through 2031.
6 days ago

Lung cancer surgery market set for $2.8b expansion by 2036 on rising cases

By region, India is emerging as the fastest-growing market, with a 7% CAGR.

Digital biomarkers market poised for $17.73b expansion by 2031 amidst remote monitoring surge

Clinical trials expand use of real-world data capture through digital monitoring tools.

Cell therapy market on track for $17.15b by 2032 amidst strong growth momentum

This is driven by strategic investments and expnding adoption amongst others.

Pharma and biotech wearables market to reach $9.97b by 2031

Growth is being driven by the healthcare industry’s adoption of the technology.

Chronic disease burden fuels demand for medical consumables across GCC

The general surgery and laparoscopic surgery segment held a dominant share in 2026.

AI-driven precision medicine market to hit $10b by 2032

This will be primarily driven by the integration of artificial intelligence in healthcare.

Contact lens and solutions market on track to reach $38b by 2032

This will be driven by the prevalence of vision disorders and lifestyle shifts.

Global diagnostic lab market poised to hit $223b

It is being driven by increasing demand for early disease diagnosis, amongst others.

Healthcare business banking solutions to reach $346 by 2034 amidst rising costs

The expansion is being driven by rising healthcare costs, amongst others.

Global diabetes care devices market to reach $76b by 2034

The expansion is being driven by the rising cases of diabetes, especially type 2 diabetes.

Global rapid diagnostic kits market to soar past $61b by 2034

It is due to the rising awareness of point-of-care diagnostics, amongst others.

Automation push to fuel 8.5% CAGR in pharma robot market through 2034

The market is estimated to ve valued at $226.24m in 2025.

Biopharma firms face $275b patent cliff as returns stall

BCG says pricing pressure, tariffs, and MFN policies are reshaping business models.